Evonik expands TEGO Foamex range with a new defoamer, Foamex 8880, which uses a unique hybrid technology containing more than 50% bio-based materials; product aligns with food contact regulations, supporting more eco-friendly coating and ink formulations

Sample article from our Bioeconomy

October 10, 2023 (press release) –

Fabian Schwane
Coating Additives
  • New and unique hybrid technology for waterborne inks and coatings
  • More than 50% bio-based materials in the non aqueous phase
  • Compliant with numerous food contact regulations


Essen, Germany. Evonik’s Coating Additives business line is expanding its TEGO® Foamex product range with a new defoamer built on unique hybrid technology that features bio-based polymer and polyether siloxane.

The new TEGO® Foamex 8880 has been developed for easy incorporation into waterborne inks at any stage of ink manufacture and even for press-side addition. The defoamer offers excellent foam prevention and great foam knockdown.

“Different technologies have different strengths. Standard siloxane-based defoamers emulsions are typically added at let-down stage, but are not necessarily the first choice for addition at the press-side,” says Courtney Thurau, Head of Global Market Segment Printing Inks at Evonik Coating Additives.

TEGO® Foamex 8880 is a non-ionic emulsion with a high content (more than 50%) of bio-based materials in the non aqueous phase. It does not contain solvents and mineral oils, and is compliant with numerous food contact regulations.

“This new defoamer highlights our commitment to support customers in developing more environmentally friendly and resource-efficient coating and inks formulations. With its truly unique property profile, TEGO® Foamex 8880 is an ideal choice for pigmented, waterborne flexo and gravure inks that are printed on paper or cardboard substrates,” says Thurau.

Evonik’s Coating Additives business line has a comprehensive portfolio for printing inks as well as a wide range of products to enhance coating and paint formulations in the automotive, architectural, industrial and other applications.

Visit also our Evonik Coating Additives LinkedIn page!

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order bioeconomy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.